Trial Details
Not RecruitingBasic Information
| Clinical ID | c2705 |
|---|---|
| Identifier | EUCTR2018-003524-36-NL |
| Trial Title | Randomized, Multicenter Study to Investigate the Efficacy of Dashboard Driven Individualized Dosing of Infliximab Compared To Standard Dosing During the Induction in Patients with Acute Severe Ulcerative Colitis - TITRATE |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Ulcerative colitis MedDRA version: 20.1_Level: LLT_Classification code 10045365_Term: Ulcerative colitis_System Organ Class: 100000004856_;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] |
| Interventions | Trade Name: Remicade Pharmaceutical Form: Powder for solution for infusion Trade Name: Metoject Pharmaceutical Form: Trade Name: Puri-Nethol Pharmaceutical Form: Tablet |
Participant Information
| Sponsor | UMC Amsterdam location AMC |
|---|---|
| City | - |
| Country/Region | Netherlands;Norway;Ireland |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |